Feng-Chun Yang - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Feng-Chun Yang

Showing results (121-130 of 126) with videos related to

Pageof 13

Sort By:

You have reached the last page of results.This site can display upto 126 results.

Cell Stem Cell|February 15, 2025

PSPC1 exerts an oncogenic role in AML by regulating a leukemic transcription program in cooperation with PU.1Juyeong Hong, Pinpin Sui, Ying Li, et al.

Cancer Cell|January 16, 2019

CARM1 Is Essential for Myeloid Leukemogenesis but Dispensable for Normal HematopoiesisSarah M Greenblatt, Na Man, Pierre-Jacques Hamard, et al.

Nature Communications|April 26, 2017

Tet2 loss leads to hypermutagenicity in haematopoietic stem/progenitor cellsFeng Pan, Thomas S Wingo, Zhigang Zhao, et al.

Proceedings of the National Academy of Sciences of the United States of America|July 3, 2013

TET1 plays an essential oncogenic role in MLL-rearranged leukemiaHao Huang, Xi Jiang, Zejuan Li, et al.

Haematologica|November 2, 2023

<i>ASXL1</i> mutations are associated with a response to alvocidib and 5-azacytidine combination in myelodysplastic neoplasmsVladimir Riabov, Qingyu Xu, Nanni Schmitt, et al.

The Lancet. Oncology|October 27, 2012

Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trialKent A Robertson, Grzegorz Nalepa, Feng-Chun Yang, et al.

Pageof 13

Search research articles

Showing results (121-130 of 126) with videos related to

Sort By:

Pageof 13

You have reached the last page of results.This site can display upto 126 results.

Cell Stem Cell|February 15, 2025

PSPC1 exerts an oncogenic role in AML by regulating a leukemic transcription program in cooperation with PU.1Juyeong Hong, Pinpin Sui, Ying Li, et al.

Cancer Cell|January 16, 2019

CARM1 Is Essential for Myeloid Leukemogenesis but Dispensable for Normal HematopoiesisSarah M Greenblatt, Na Man, Pierre-Jacques Hamard, et al.

Nature Communications|April 26, 2017

Tet2 loss leads to hypermutagenicity in haematopoietic stem/progenitor cellsFeng Pan, Thomas S Wingo, Zhigang Zhao, et al.

Proceedings of the National Academy of Sciences of the United States of America|July 3, 2013

TET1 plays an essential oncogenic role in MLL-rearranged leukemiaHao Huang, Xi Jiang, Zejuan Li, et al.

Haematologica|November 2, 2023

<i>ASXL1</i> mutations are associated with a response to alvocidib and 5-azacytidine combination in myelodysplastic neoplasmsVladimir Riabov, Qingyu Xu, Nanni Schmitt, et al.

The Lancet. Oncology|October 27, 2012

Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trialKent A Robertson, Grzegorz Nalepa, Feng-Chun Yang, et al.

Pageof 13